Stay updated on Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history.
    Difference
    0.0%
    Check dated 2026-03-11T17:49:09.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added revision v3.4.2 to the history; removed the funding-lapse notice and revision v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T05:32:37.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the page revision updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:21:29.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Updates to the history page include a Show glossary option, green and red color-coding explanations for additions and deletions, and a new revision label (v3.4.0) replacing v3.3.4. These changes are cosmetic UI updates and do not modify the underlying trial records; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-01-28T03:25:24.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the Record History page.
    Difference
    0.0%
    Check dated 2026-01-14T01:34:26.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer area now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:38:19.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.